Outcomes following transoral robotic surgery: Supraglottic laryngectomy

Objectives/Hypothesis: To describe a single center outcomes following transoral robotic surgery for supraglottic laryngectomy (TORS–SL). Study Design: Prospective data collection. Methods: Patient records receiving TORS–SL for squamous cell carcinoma (SCCA) with at least 12 months follow‐up fit incl...

Full description

Saved in:
Bibliographic Details
Published in:The Laryngoscope 2013-01, Vol.123 (1), p.208-214
Main Authors: Mendelsohn, Abie H., Remacle, Marc, Van Der Vorst, Sebastien, Bachy, Vincent, Lawson, Georges
Format: Article
Language:English
Subjects:
cancer
Carcinoma, Squamous Cell - mortality
Carcinoma, Squamous Cell - surgery
da Vinci
Female
Follow-Up Studies
functional outcomes
head and neck
Head and Neck Neoplasms - mortality
Head and Neck Neoplasms - surgery
Humans
Laryngeal
Laryngeal Neoplasms - mortality
Laryngeal Neoplasms - pathology
Laryngeal Neoplasms - surgery
Laryngectomy - adverse effects
Laryngectomy - methods
Larynx - pathology
Larynx - surgery
Level of Evidence: 4
Male
Medical research
Neoplasm Recurrence, Local - mortality
Neoplasm Recurrence, Local - surgery
Ostomy
Postoperative Complications
Prognosis
Prospective Studies
Robotics - methods
Squamous Cell Carcinoma of Head and Neck
Survival Analysis
Treatment Outcome
tumor
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objectives/Hypothesis: To describe a single center outcomes following transoral robotic surgery for supraglottic laryngectomy (TORS–SL). Study Design: Prospective data collection. Methods: Patient records receiving TORS–SL for squamous cell carcinoma (SCCA) with at least 12 months follow‐up fit inclusion for this study. Two patients with previous SCCA were excluded. Results: 18 patients (14 male, 4 female) were included in the study, having a mean follow‐up time of 28.1 months (SD = 12.1). All patients had negative margins confirmed on final pathology. Nine (50%) patients received postoperative chemoradiation therapy for advanced neck disease. No (0%) patients received tracheostomy or gastrostomy tubes. There were no (0%) local recurrences, and three (16.7%) regional recurrences. Five (27.8%) patients experienced temporary postoperative complications. Overall 2‐year outcomes reached 83%, 100%, and 89% for locoregional control, disease‐specific survival, and overall survival respectively. Conclusions: Initial outcomes for TORS–SL are encouraging and are comparable to previously described treatment modalities. Larger studies are encouraged. Laryngoscope, 2013
ISSN:0023-852X
1531-4995
DOI:10.1002/lary.23621